DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target

Cancer Research

Volumn 70, Issue 5, 2010, Pages 1766-1772

  Qu, Zhaoxia ^a,b   Yan, Pengrong ^a,b   Fu, Jing ^a,b   Jiang, Jing ^a   Grusby, Michael J ^c   Smithgall, Thomas E ^b   Xiao, Gutian ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIM KINASE; PROTEIN P2;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL ANCHORAGE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVATION; GROWTH DISORDER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; AZACITIDINE; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA MODIFICATION METHYLASES; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICE, SCID; MICROFILAMENT PROTEINS; NF-KAPPA B; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 77950193822     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3263     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249
2. Burstein E, Fearon ER. Colitis and cancer: a tale of inflammatory cells and their cytokines. J Clin Invest 2008;118:464-467
3. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18:1-5.
4. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-296
5. Rogler G, Brand K, Vogl D, et al. Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998;115:357-369
6. Lind DS, Hochwald SN, Malaty J, et al. Nuclear factor-κB is upregulated in colorectal cancer. Surgery 2001;130:363-369
7. Yu HG, Yu LL, Yang Y, et al. Increased expression of RelA/nuclear factor-κB protein correlates with colorectal tumorigenesis. Oncology 2003;65:37-45.
8. Hardwick JC, van den Brink GR, Offerhaus GJ, van Deventer SJ, Peppelenbosch MP. NF-κB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 2001;20:819-827
9. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000;14:145-153
10. Jänne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 2000;342:1960-1968
11. Xiao G. Autophagy and NF-κB: fight for fate. Cytokine Growth Factor Rev 2007;8:233-243
12. Xiao G, Rabson A, Young W, Qing G, Qu Z. Alternative pathways of NF-κB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 2006;17:281-293
13. Saccani S, Marazzi I, Beg AA, Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response. J Exp Med 2004;200:107-113
14. Tanaka T, Grusby MJ, Kaisho T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 2007;8:584-591
15. Yan P, Fu J, Qu Z, et al. PDLIM2 suppresses HTLV-I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood 2009;113:4370-4380
16. Qing G, Qu Z, Xiao G. Stabilization of basally translated NF-κB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-κB2 p100. J Biol Chem 2005;280:40578-40582
17. Yan P, Qu Z, Ishikawa C, Mori N, Xiao G. Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein Tax. Neoplasia 2009;11:1036-1041
18. Wang XM, Terasaki PI, Rankin GW, Jr., et al. A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol 1993;37:264-270
19. Qing G, Qu Z, Xiao G. Proteasome-mediated endoproteolytic processing of the NF-κB2 precursor at the κB promoter. Proc Natl Acad Sci U S A 2007;104:5324-5329
20. Garcia-Manero G. Demethylating agents in myeloid malignancies. Curr Opin Oncol 2008;20:705-710
21. Qu Z, Fu J, Yan P, Cheng S, Xiao G. Epigenetic repression of PDLIM2: implications for the biology and treatment of breast cancer. J Biol Chem. In revision 2010.